Clinical research is continually searching for new biomarkers, which will
give an early indication of disease, or which can be used as an indication
of disease progression during its early stages.The
use of statistical models allows the development of entirely new markers,
such as changes in 3-dimensional shape. Additionally, the technology
be used to improve upon existing techniques, but with increased measurement
precision
Designing your trial to take greatest advantage of
this new technology requires careful planning, and imorphics are able to act
as your partner in study design, and will work with you to validate the
approach, and to configure the software to support your particular study.
